Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions

Inclusion Criteria: * Subjects will be males, non-smokers * Between 18 and 55 years of age * Subjects weight will be within 15% of their ideal body weight, based on Table of "Desirable Weight of Adults", Metropolitan Life Insurance Company, 1983 * Subjects should read, sign and date an Informed Consent Form prior to any study procedures * Subjects must complete all screening procedures within 28 days prior to the administration of the study medication Exclusion Criteria: * Clinically significant anormalities found during medical screening * Any clinically significant history of ongoing problems or problems known to interfere with the absorption, distribution, metabolism or excretion of drugs of drugs * Clinically significant illnesses within 4 weeks of the administration of study medication * Abnormal laboratory tests judged clinically significant * ECG or vital sign abnormalities (clinically significant) * History of allergic reactions to heparin * Any food allergies, intolerances, restrictions, or special diet which in the opinion of the medical subinvestigator, contraindicates the subject's participation in the study * History of severe allergies or hay fever * Active asthma or bronchospasm * Positive urine drug screen at screening * Positive testing for hepatitis B, hepatitis C or HIV at screening * Use of investigational drug or participation in an investigational study, within 30 days prior to administration of the study medication * Recent donation of plasma (500 mL…